New Survey Data Reveals Prior Authorization or Other Utilization Management Strategies, Eligibility Requirements, Annual Maximum as Leading Cost Control Methods A new survey report from the International Foundation of Employee Benefit Plans reveals updated Canadian employer coverage and cost-control mechanisms surrounding glucagon-like […]
New Survey Data Reveals Rise of GLP-1 Drug Claims, With Utilization Management and Eligibility Requirements as Leading Cost-Control Mechanisms A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage and claims representation surrounding glucagon-like peptide-1 […]
The 2024 edition of the International Foundation’s Employee Benefits Survey addresses many topics that organizations struggle with to keep benefit cost down for their employees. This includes health care plans and prescription drugs. Prior research conducted in 2024 by the International Foundation […]
New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Has Increased to Almost Nine Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage surrounding glucagon-like peptide-1 (GLP-1) […]
